Description
TB-500 10 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide supplied as a 10 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Identification
| Product name | TB-500 |
| Also listed as | Thymosin β4–related research peptide |
| Supplier | Opti-Gen Peptides |
| Contents | 10 mg per vial |
| Common research identities | Full thymosin β4 (43 aa; CAS 77591-33-4) or short actin-binding fragment (e.g. Ac-LKKTETQ) |
| Intended use | Laboratory / in-vitro research only |
Confirm the exact sequence on the lot COA. Not BPC-157.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.
Published research context (not product claims)
Thymosin β4 is a G-actin–sequestering peptide used in cell-motility and cytoskeleton assays. The short motif LKKTETQ is the region often discussed in actin-binding papers.
Catalogue name TB-500 is used for both the full 43-aa peptide and truncated fragments. Literature on one form must not be applied blindly to the other.
Injury and wound papers are experimental models. They are not claims that this vial heals tissue.
Thymosin β4 / TB-500 appears in WADA discussions. That is an anti-doping listing, not a use instruction. No UK marketing authorisation.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.